An Immunoreceptor-Targeting Strategy with Minimalistic C3b Peptide Fusion Enhances SARS-CoV-2 RBD mRNA Vaccine Immunogenicity
Published in International Journal of Nanomedicine, 7201-7214, 2024
A novel immunoreceptor-targeting strategy incorporating C3b peptide fusion to improve SARS-CoV-2 RBD mRNA vaccine immunogenicity.
Recommended citation: CT Chiu, HH Tsai, JY Chen, CMJ Hu, HW Chen. (2024). "An Immunoreceptor-Targeting Strategy with Minimalistic C3b Peptide Fusion Enhances SARS-CoV-2 RBD mRNA Vaccine Immunogenicity." International Journal of Nanomedicine:7201-7214.
Download Paper